Advertisement

Uncategorized

Histogenics, a biotech company focused on developing an implantable tissue repair platform for cartilage damage to the knee, filed with the U.S. Securities and Exchange Commission to raise up to $65 million in an initial public offering, according to a…

Advertisement

  This issue of Becker’s Spine Review includes expertise from some of the top spine surgeon thought leaders in the field today discussing topics such as sustainable spine care, bundled payments and data gathering. The issue also features two key…

        Deconstructing the Cost of Spine Care: Where Dollars Really Go The media has paid a lot of attention to physician compensation recently as a means to decrease the cost of care, but among spine patients —…

Advertisement